Caricamento...

OnabotulinumtoxinA for chronic migraine: a critical appraisal

Chronic migraine (CM) is a severe disabling condition with a few available evidence-based management options. OnabotulinumtoxinA (onaBoNTA) is approved for use in a number of disorders. Its benefits and potential use in migraine were observed incidentally while treating patients cosmetically for wri...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Ther Clin Risk Manag
Autori principali: Gooriah, Rubesh, Ahmed, Fayyaz
Natura: Artigo
Lingua:Inglês
Pubblicazione: Dove Medical Press 2015
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4492656/
https://ncbi.nlm.nih.gov/pubmed/26170679
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S76964
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !